查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
免疫組化市場 - 2018-2028 年全球行業規模、佔有率、趨勢、機會和預測F 按產品、應用、最終用戶、地區和競爭情況分類
市場調查報告書
商品編碼
1309862

免疫組化市場 - 2018-2028 年全球行業規模、佔有率、趨勢、機會和預測F 按產品、應用、最終用戶、地區和競爭情況分類

Immunohistochemistry Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028F Segmented by Product, By Application, By End User, By Region and By Competition
出版日期: | 出版商: TechSci Research | 英文 113 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

全球免疫組化市場預計將在預測期內實現令人矚目的成長。這主要歸因於在免疫組化中實施自動化和機器學習的需求不斷成長，以及全球各地推出了技術先進的免疫組化解決方案。此外，產品審批的增加和用於疾病診斷的技術先進的IHC 系統的推出也進一步推動了預測期內市場的成長。同樣，製藥和生物技術行業研發支出的成長也是推動市場成長的主要因素。此外，對個性化醫療、癌症基因組學研究的日益青睞，以及患者參與度要求的不斷提高，預計將在預測期內推動市場需求。同樣，在預測期內，抗體在病理學、神經病理學和血液病理學中越來越多的應用預計將進一步提高免疫組化市場的需求。 2021 年8 月，FDA 批准了羅氏公司的VENTANA MMR RxDx Panel，用於鑑定符合抗PD-1 免疫療法條件的dMMR 實體瘤患者。

慢性病患病率不斷上升

癌症發病率的上升以及老年人口的增加是預計將在預測期內進一步推動市場成長的主要因素之一。根據歐盟委員會聯合研究委員會2020 年7 月發布的報告，預計2020 年歐盟將診斷出約270 萬例癌症新病例（不包括非黑色素瘤癌症），而乳腺癌將是最常見的癌症形式，2020 年將新增約35.5 萬例病例。此外，慢性腎臟疾病的發病率不斷上升，預計將在預測期內帶來利潤豐厚的成長。此外，通過鑑定酶、腫瘤特異性抗原、腫瘤抑制基因、癌基因和腫瘤細胞增殖標記物來分析腫瘤的需求不斷成長，預計將在預測期內提高免疫組化市場的需求。此外，隨著心血管疾病、心臟病、哮喘和慢性阻塞性肺部疾病發病率的上升，以及患者到醫院就診人數的增加，也會在預測期內促進免疫組化市場的需求。

個性化醫療需求不斷成長

在預測期內，非小細胞肺癌患者對個性化醫療的需求不斷成長，從而提高了對免疫組化的需求。此外，這項技術通過對腫瘤進行最完整、最準確的組織學亞型分析，有助於做出適當的治療決策，從而在未來幾年內提高市場需求。同樣，在預測期內，能檢測BRAF V600E 和IDH1 R132H 等突變蛋白的免疫組化檢測方法越來越多，這將進一步推動市場的發展。免疫組化可替代或輔助分子檢測。這些技術具有高度的可重複性、合理的技術和解釋複雜性，而且成本較低。多重和突變特異性免疫組化測定的不斷發展是重要的創新，預計將在預測期內進一步推動市場的成長。根據2020 年7 月發表在《實驗室研究》（Laboratory Investigation）雜誌上的研究，免疫組化（IHC）和原位雜合技術（ISH）測定被用於檢測COVID-19 感染。

最新進展

  • 2022 年6 月，羅氏公司推出HPV 自採樣解決方案，擴大了宮頸癌篩查的選擇範圍。
  • 2022 年2 月， Moderna 與賽默飛世爾科技公司宣布開展長期戰略合作，在美國生產Spikevax 疫苗，用於診斷COVID-19 和該管線中其他在研mRNA 藥物。
  • 2022 年2 月，一種新型基因分析儀為桑格測序和片段分析帶來了先進功能，即毛細管電泳，它實現了桑格測序和片段分析，這對於改進臨床研究和推進科學發現至關重要。

可客製化

有了給定的市場數據，TechSci Research 可根據公司的具體需求提供客製化服務。報告可提供以下客製化選項：

公司資訊

  • 其他市場參與者（最多五家）的詳細分析和概況。

目錄

第1 章：產品概述

  • 市場定義
  • 市場範圍
    • 覆蓋市場
    • 研究年份
    • 主要市場細分

第2 章：研究方法

  • 研究目的
  • 基準方法
  • 主要行業合作夥伴
  • 主要協會和二手資料來源
  • 預測方法
  • 數據三角測量與驗證
  • 假設和限制

第3 章：執行摘要

  • 市場概述
  • 主要市場細分概述
  • 主要市場參與者概述
  • 主要地區/國家概述
  • 市場驅動因素、挑戰和趨勢概述

第4章：客戶之聲

第5章：全球免疫組化市場前景

  • 市場規模與預測
    • 按價值
  • 市場佔有率與預測
    • 按產品（抗體、設備、試劑、試劑盒）
    • 按應用（診斷、藥物檢測、法醫應用）
    • 按最終用戶（醫院和診斷實驗室、研究所、其他）
    • 按地區（北美、歐洲、亞太地區、南美、中東和非洲）
    • 按公司（2022 年）
  • 市場地圖
    • 按產品
    • 按應用
    • 按最終用戶
    • 按地區

第6 章: 北美免疫組化市場前景

  • 市場規模與預測
    • 按價值
  • 市場佔有率與預測
    • 按產品（抗體、設備、試劑、試劑盒）
    • 按應用（診斷、藥物檢測、法醫應用）
    • 按最終用戶（醫院和診斷實驗室、研究所、其他）
    • 按國家
  • 北美洲：國家分析
    • 美國
    • 加拿大
    • 墨西哥

第7 章: 歐洲免疫組化市場前景

  • 市場規模與預測
    • 按價值
  • 市場佔有率與預測
    • 按產品（抗體、設備、試劑、試劑盒）
    • 按應用（診斷、藥物檢測、法醫應用）
    • 按最終用戶（醫院和診斷實驗室、研究所、其他）
    • 按國家
  • 歐洲：國家分析
    • 法國
    • 德國
    • 英國
    • 義大利
    • 西班牙

第8 章: 亞太地區免疫組化市場前景

  • 市場規模與預測
    • 按價值
  • 市場佔有率與預測
    • 按產品（抗體、設備、試劑、試劑盒）
    • 按應用（診斷、藥物檢測、法醫應用）
    • 按最終用戶（醫院和診斷實驗室、研究所、其他）
    • 按國家
  • 亞太地區：國家分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳大利亞

第9 章: 南美免疫組化市場前景

  • 市場規模與預測
    • 按價值
  • 市場佔有率與預測
    • 按產品（抗體、設備、試劑、試劑盒）
    • 按應用（診斷、藥物檢測、法醫應用）
    • 按最終用戶（醫院和診斷實驗室、研究所、其他）
    • 按國家
  • 南美洲：國家分析
    • 巴西
    • 阿根廷
    • 哥倫比亞

第10 章: 中東和非洲免疫組化市場前景

  • 市場規模與預測
    • 按價值
  • 市場佔有率與預測
    • 按產品（抗體、設備、試劑、試劑盒）
    • 按應用（診斷、藥物檢測、法醫應用）
    • 按最終用戶（醫院和診斷實驗室、研究所、其他）
    • 按國家
  • 中東和非洲：國家分析
    • 南非免疫組化
    • 沙烏地阿拉伯免疫組化
    • 阿拉伯聯合大公國免疫組化

第11 章：市場動態

  • 驅動因素
  • 挑戰

第12 章：市場趨勢與發展

  • 近期發展
  • 合併與收購
  • 產品發布

第13 章：全球免疫組化市場：SWOT 分析

第14章：波特五力分析法

  • 行業競爭
  • 新進入者的潛力
  • 供應商的力量
  • 客戶的力量
  • 替代產品的威脅

第15 章：競爭格局

  • 業務概述
  • 產品供應
  • 近期發展
  • 財務狀況（報告）
  • 主要人員
  • SWOT 分析
    • Thermo Fisher Scientific Inc.
    • F.Hoffmann-La Roche Ltd.
    • Merck KGaA.
    • Danaher Corporation.
    • Perkinelmer, Inc.
    • Bio-Rad Laboratories, Inc.
    • Cell Signaling Technology Inc.
    • Bio SB.
    • Agilent Technologies, Inc.
    • Abcam Plc.

第16 章：戰略建議

簡介目錄
Product Code: 14820

Global Immunohistochemistry market is anticipated to witness impressive growth during the forecast period. This can be ascribed to the rising demand for the implementation of automation and machine learning in immunohistochemistry, along with the introduction of technologically advanced immunohistochemistry solutions across the globe. Moreover, the rise in product approvals and the launch of technologically advanced IHC systems for disease diagnosis are further driving the growth of the market during the forecast period. Similarly, growing research and development expenditures in the pharmaceutical and biotechnology industries are the major factors driving the growth of the market. Moreover, growing preference for personalized medicine, cancer genomics studies, and increasing patient engagement requirements is expected to drive the demand for the market during the forecast period. Similarly, the growing usage of antibodies in pathology, neuropathology, and hematopathology is expected to further enhance the demand for the immunohistochemistry market during the forecast period. In August 2021, the FDA approved Roche's VENTANA MMR RxDx Panel to identify dMMR solid tumor patients eligible for anti-PD-1 immunotherapy.

Growing Prevalence of Chronic Diseases

The growing prevalence of cancer, along with the increasing geriatric population, is one of the major factors which is expected to further boost the growth of the market during the forecast period. As per the Joint Research Commission's report European Commission released in July 2020, it was estimated that in 2020 about 2.7 million (excluding non-melanoma cancer) new cancer cases would be diagnosed in the European Union, and breast cancer will be the most prevalent form of cancer with about 355,000 new cases in 2020. Moreover, the growing prevalence of chronic kidney disorders is expected to create lucrative growth during the forecast period. Furthermore, growing demand for analyzing tumors by identification of enzymes, tumor-specific antigens, tumor suppressor genes, oncogenes, and tumor cell proliferation markers is expected to enhance demand for the immunohistochemistry market during the forecast period. Moreover, the growing incidence of cardiovascular diseases, heart diseases, asthma, and chronic obstructive pulmonary diseases, along with the rising number of patient visits to hospitals, can enhance the demand for the immunohistochemistry market during the forecast period.

Growing Demand for Personalized Medicine

The growing demand for personalized medicine for non-small cell lung cancer patients enhanced the demand for immunohistochemistry during the forecast period. Moreover, this technique helps in making appropriate treatment decisions by performing the most complete and accurate histological subtyping of tumors possible, which can enhance the demand for the market over the years. Similarly, the growing availability of immunohistochemistry assays that can detect mutant proteins such as BRAF V600E and IDH1 R132H will further drive the market during the forecast period. It can provide a helpful replacement or adjunct for molecular testing. These techniques are highly reproducible, entail reasonable technical and interpretation complexity, and are also available at lesser costs. The growing development of multiplex and mutation-specific immunohistochemistry assays represents important innovations that are expected to further drive the growth of the market during the forecast period. According to research published in the Laboratory Investigation journal in July 2020, the immunohistochemical (IHC) and in situ hybridization (ISH) assays were utilized for detecting COVID-19 infection.

Market Segmentation

Global Immunohistochemistry market can be segmented on the basis of product, application, end-user, and by region. Based on the product, the market can be segmented into antibodies, equipment, reagents, and kits. On the basis of application, the market can be segmented into diagnostics, drug testing, and forensic applications. Based on end-user, the market can be further divided into hospitals & diagnostic laboratories, research institutes, and others. On the basis of region, North America dominated the market among Asia Pacific, Europe, Middle East & Africa, and South America. Among the different countries, the United States dominated the global immunohistochemistry market on account of the growing prevalence of chronic diseases in the country.

Recent Developments

  • In June 2022, Roche launched HPV self-sampling solution and expanded cervical cancer screening options.
  • In February 2022, Moderna and Thermo Fisher Scientific announced a long-term strategic collaboration for manufacturing of Spikevax vaccine in the U.S. for diagnosis of COVID-19 and other investigational mRNA medicines in this pipeline.
  • In February 2022, a new genetic analyzer brought advanced capabilities to sanger sequencing and fragment analysis, which is called capillary electrophoresis, and it enables sanger sequencing and fragment analysis, which is essential for improving clinical research and advancing scientific discovery.

Market Players

Thermo Fisher Scientific Inc., F.Hoffmann-La Roche Ltd., Merck KGaA., Danaher Corporation., Perkinelmer, Inc., Bio-Rad Laboratories, Inc., Cell Signaling Technology Inc., Bio SB., Agilent Technologies, Inc. are some of the leading players operating in the global Immunohistochemistry market.

Report Scope

In this report, global Immunohistochemistry market has been segmented into the following categories, in addition to the industry trends, which have also been detailed below:

Immunohistochemistry Market, By Product:

  • Antibodies
  • Equipment
  • Reagents
  • Kits

Immunohistochemistry Market, By Application:

  • Diagnostics
  • Drug Testing
  • Forensic applications

Immunohistochemistry Market, By End User:

  • Hospitals & Diagnostic Laboratories
  • Research Institutes
  • Others

Immunohistochemistry Market, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • Germany
    • United Kingdom
    • Italy
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
    • Australia
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Immunohistochemistry Market.

Available Customizations

With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Immunohistochemistry Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Product (Antibodies, Equipment, Reagents, Kits)
    • 5.2.2. By Application (Diagnostics, Drug Testing, Forensic applications)
    • 5.2.3. By End User (Hospitals & Diagnostic Laboratories, Research Institutes, Others)
    • 5.2.4. By Region (North America, Europe, Asia Pacific, South America, Middle East & Africa)
    • 5.2.5. By Company (2022)
  • 5.3. Market Map
    • 5.3.1 By Product
    • 5.3.2 By Application
    • 5.3.3 By End User
    • 5.3.4 By Region

6. North America Immunohistochemistry Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Product (Antibodies, Equipment, Reagents, Kits)
    • 6.2.2. By Application (Diagnostics, Drug Testing, Forensic applications)
    • 6.2.3. By End User (Hospitals & Diagnostic Laboratories, Research Institutes, Others)
    • 6.2.4. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Immunohistochemistry Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Product
        • 6.3.1.2.2. By Application
        • 6.3.1.2.3. By End User
    • 6.3.2. Canada Immunohistochemistry Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Product
        • 6.3.2.2.2. By Application
        • 6.3.2.2.3. By End User
    • 6.3.3. Mexico Immunohistochemistry Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Product
        • 6.3.3.2.2. By Application
        • 6.3.3.2.3. By End User

7. Europe Immunohistochemistry Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Product (Antibodies, Equipment, Reagents, Kits)
    • 7.2.2. By Application (Diagnostics, Drug Testing, Forensic applications)
    • 7.2.3. By End User (Hospitals & Diagnostic Laboratories, Research Institutes, Others)
    • 7.2.4. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. France Immunohistochemistry Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Product
        • 7.3.1.2.2. By Application
        • 7.3.1.2.3. By End User
    • 7.3.2. Germany Immunohistochemistry Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Product
        • 7.3.2.2.2. By Application
        • 7.3.2.2.3. By End User
    • 7.3.3. United Kingdom Immunohistochemistry Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Product
        • 7.3.3.2.2. By Application
        • 7.3.3.2.3. By End User
    • 7.3.4. Italy Immunohistochemistry Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Product
        • 7.3.4.2.2. By Application
        • 7.3.4.2.3. By End User
    • 7.3.5. Spain Immunohistochemistry Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Product
        • 7.3.5.2.2. By Application
        • 7.3.5.2.3. By End User

8. Asia-Pacific Immunohistochemistry Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Product (Antibodies, Equipment, Reagents, Kits)
    • 8.2.2. By Application (Diagnostics, Drug Testing, Forensic applications)
    • 8.2.3. By End User (Hospitals & Diagnostic Laboratories, Research Institutes, Others)
    • 8.2.4. By Country
  • 8.3. Asia-Pacific: Country Analysis
    • 8.3.1. China Immunohistochemistry Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Product
        • 8.3.1.2.2. By Application
        • 8.3.1.2.3. By End User
    • 8.3.2. India Immunohistochemistry Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Product
        • 8.3.2.2.2. By Application
        • 8.3.2.2.3. By End User
    • 8.3.3. Japan Immunohistochemistry Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Product
        • 8.3.3.2.2. By Application
        • 8.3.3.2.3. By End User
    • 8.3.4. South Korea Immunohistochemistry Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Product
        • 8.3.4.2.2. By Application
        • 8.3.4.2.3. By End User
    • 8.3.5. Australia Immunohistochemistry Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Product
        • 8.3.5.2.2. By Application
        • 8.3.5.2.3. By End User

9. South America Immunohistochemistry Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Product (Antibodies, Equipment, Reagents, Kits)
    • 9.2.2. By Application (Diagnostics, Drug Testing, Forensic applications)
    • 9.2.3. By End User (Hospitals & Diagnostic Laboratories, Research Institutes, Others)
    • 9.2.4. By Country
  • 9.3. South America: Country Analysis
    • 9.3.1. Brazil Immunohistochemistry Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Product
        • 9.3.1.2.2. By Application
        • 9.3.1.2.3. By End User
    • 9.3.2. Argentina Immunohistochemistry Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Product
        • 9.3.2.2.2. By Application
        • 9.3.2.2.3. By End User
    • 9.3.3. Colombia Immunohistochemistry Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Product
        • 9.3.3.2.2. By Application
        • 9.3.3.2.3. By End User

10. Middle East and Africa Immunohistochemistry Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Product (Antibodies, Equipment, Reagents, Kits)
    • 10.2.2. By Application (Diagnostics, Drug Testing, Forensic applications)
    • 10.2.3. By End User (Hospitals & Diagnostic Laboratories, Research Institutes, Others)
    • 10.2.4. By Country
  • 10.3. MEA: Country Analysis
    • 10.3.1. South Africa Immunohistochemistry Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Product
        • 10.3.1.2.2. By Application
        • 10.3.1.2.3. By End User
    • 10.3.2. Saudi Arabia Immunohistochemistry Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Product
        • 10.3.2.2.2. By Application
        • 10.3.2.2.3. By End User
    • 10.3.3. UAE Immunohistochemistry Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Product
        • 10.3.3.2.2. By Application
        • 10.3.3.2.3. By End User

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Recent Development
  • 12.2. Mergers & Acquisitions
  • 12.3. Product Launches

13. Global Immunohistochemistry Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Business Overview
  • 15.2. Product Offerings
  • 15.3. Recent Developments
  • 15.4. Financials (As Reported)
  • 15.5. Key Personnel
  • 15.6. SWOT Analysis
    • 15.6.1 Thermo Fisher Scientific Inc.
    • 15.6.2 F.Hoffmann-La Roche Ltd.
    • 15.6.3 Merck KGaA.
    • 15.6.4 Danaher Corporation.
    • 15.6.5 Perkinelmer, Inc.
    • 15.6.6 Bio-Rad Laboratories, Inc.
    • 15.6.7 Cell Signaling Technology Inc.
    • 15.6.8 Bio SB.
    • 15.6.9 Agilent Technologies, Inc.
    • 15.6.10 Abcam Plc.

16. Strategic Recommendations